October 25, 2017 / 2:53 PM / 2 months ago

BRIEF-Shenzhen Hepalink Pharmaceutical sees FY 2017 net profit down 62.21 pct to 82.36 pct

Oct 25(Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd :

* Sees FY 2017 net profit to decrease by 62.21 percent to 82.36 percent, or to be 70 million yuan to 150 million yuan

* Says FY 2016 net profit was 396.9 million yuan

* The reasons for the forecast are increased heparin raw material purchase price and improved financial expense and decreased investment return Source text in Chinese: goo.gl/RqDLqQ Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below